Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: rankin bd. J Am Acad Dermatol. 2025 Jan 20:S0190-9622(25)00006-4. doi: 10.1016/j.jaad.2024.12.034. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 39831882 Free article. No abstract available.
Evaluation of a Question Prompt List About Cardiovascular Disease Risk and Prevention After Hypertensive Pregnancy: A Pilot Study.
Dhakal S, Rankin B, Assaf T, Baker J, Chisick L, Colella T, Dayan N, Dobbins M, Grace S, Gundy S, McCarthy SO, Meng Z, Murray-Davis B, Neil-Sztramko S, Nerenberg K, Sia W, Smith G, Timofeeva M, Gagliardi AR. Dhakal S, et al. Among authors: rankin b. Health Expect. 2024 Dec;27(6):e70085. doi: 10.1111/hex.70085. Health Expect. 2024. PMID: 39474989 Free PMC article.
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review.
Rankin BD, Sood S, Park YJ, Rimke A, Abduelmula A, Georgakopoulos JR, Maliyar K, Leung F, Stark LA, Devani AR, Yeung J, Prajapati VH. Rankin BD, et al. Dermatitis. 2024 Oct 24. doi: 10.1089/derm.2024.0208. Online ahead of print. Dermatitis. 2024. PMID: 39446652 No abstract available.
Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study.
Bagit A, Maliyar K, Mansour M, Georgakopoulos JR, Rankin B, Lytvyn Y, Zaaroura H, Park YJ, Wang E, Mufti A, Torres T, Le AM, Vender R, Prajapati VH, Yeung J. Bagit A, et al. Among authors: rankin b. J Eur Acad Dermatol Venereol. 2024 Oct 15. doi: 10.1111/jdv.20373. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39403817 No abstract available.
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.
Klinkardt U, Schunk M, Ervin J, Schindler C, Sugimoto D, Rankin B, Amann R, Monti M, Kutschenko A, Schumacher C, Huber K, Zeder A, Heikkila N, Didierlaurent AM, Schwarz SE, Derouazi M. Klinkardt U, et al. Among authors: rankin b. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410574. doi: 10.1080/21645515.2024.2410574. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39397784 Free PMC article. Clinical Trial.
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study.
Bagit A, Maliyar K, Mansour M, Georgakopoulos JR, Rankin BD, Lytvyn Y, Zaaroura H, Park YJ, Wang OJE, Mufti A, Torres T, Le AM, Vender R, Prajapati VH, Yeung J. Bagit A, et al. Among authors: rankin bd. J Cutan Med Surg. 2024 Nov-Dec;28(6):604-605. doi: 10.1177/12034754241274300. Epub 2024 Sep 3. J Cutan Med Surg. 2024. PMID: 39225249 No abstract available.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review.
Sood S, Rimke A, Rankin BD, Abduelmula A, Georgakopoulos JR, Maliyar K, Bagit A, Leung F, Devani AR, Vender R, Yeung J, Prajapati VH. Sood S, et al. Among authors: rankin bd. J Am Acad Dermatol. 2024 Dec;91(6):1265-1267. doi: 10.1016/j.jaad.2024.07.1515. Epub 2024 Aug 23. J Am Acad Dermatol. 2024. PMID: 39182686 Free article. No abstract available.
A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older.
Wassil J, Sisti M, Fairman J, Rankin B, Clark J, Bennett S, Johnson D, Migone TS, Nguyen K, Paschenko A, Sauer P, Iki S, Hanson ME, Simon JK. Wassil J, et al. Among authors: rankin b. Vaccine. 2024 Nov 14;42(25):126124. doi: 10.1016/j.vaccine.2024.07.025. Epub 2024 Jul 17. Vaccine. 2024. PMID: 39025698 Free article. Clinical Trial.
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Short-Term (Week 8-20) Data from a Real-World Multicenter Retrospective Review.
Rankin BD, Sood S, Park YJ, Rimke A, Abduelmula A, Georgakopoulos JR, Leung F, Stark LA, Devani AR, Yeung J, Prajapati VH. Rankin BD, et al. Dermatitis. 2024 Jun 24. doi: 10.1089/derm.2024.0097. Online ahead of print. Dermatitis. 2024. PMID: 38913326 No abstract available.
146 results